Back to top

Image: Bigstock

Aldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7%

Read MoreHide Full Article

Aldeyra Therapeutics, Inc. (ALDX - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.37 to $7.35 in the past one-month time frame.

In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Aldeyra Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the Med-Drugs industry is Corcept Therapeutics Incorporated (CORT - Free Report) , with a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ALDX going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Corcept Therapeutics Incorporated (CORT) - free report >>

Aldeyra Therapeutics, Inc. (ALDX) - free report >>

Published in